KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.20 $5.74 Thursday, 25th Apr 2024 VTGN stock ended at $4.70. This is 0.424% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.71% from a day low at $4.55 to a day high of $4.81.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
Feb 14, 2023 $6.90 $6.90 $6.30 $6.90 176 373
Feb 13, 2023 $5.40 $6.90 $5.10 $6.90 379 803
Feb 10, 2023 $4.50 $6.90 $4.50 $5.40 1 037 383
Feb 09, 2023 $4.80 $5.10 $4.20 $4.20 427 957
Feb 08, 2023 $6.30 $6.60 $5.40 $5.70 419 193
Feb 07, 2023 $7.80 $8.10 $6.30 $7.80 226 293
Feb 06, 2023 $9.60 $10.20 $7.50 $7.50 434 497
Feb 03, 2023 $8.40 $9.60 $8.40 $9.00 281 767
Feb 02, 2023 $7.80 $9.00 $7.50 $8.10 276 520
Feb 01, 2023 $7.80 $8.10 $6.90 $7.50 192 783
Jan 31, 2023 $6.90 $8.10 $6.30 $7.80 431 533
Jan 30, 2023 $6.30 $6.90 $6.00 $6.90 217 837
Jan 27, 2023 $5.70 $6.60 $5.70 $6.30 295 547
Jan 26, 2023 $5.40 $5.70 $5.40 $5.70 107 887
Jan 25, 2023 $5.40 $5.70 $5.10 $5.40 149 623
Jan 24, 2023 $5.40 $5.70 $5.40 $5.40 117 817
Jan 23, 2023 $5.10 $5.40 $5.10 $5.40 107 687
Jan 20, 2023 $4.80 $5.10 $4.80 $5.10 113 710
Jan 19, 2023 $5.10 $5.10 $4.50 $4.80 140 813
Jan 18, 2023 $5.70 $6.00 $5.10 $5.10 203 207
Jan 17, 2023 $4.80 $5.70 $4.80 $5.40 334 020
Jan 13, 2023 $4.80 $4.80 $4.80 $4.80 72 483
Jan 12, 2023 $4.80 $5.10 $4.80 $4.80 151 687
Jan 11, 2023 $4.50 $5.10 $4.50 $5.10 153 200
Jan 10, 2023 $4.50 $5.10 $4.50 $4.80 232 100
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT